The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hislop Colin since 2010.
The trader's CIK number is 1314902.
At the time of the last reporting, Hislop Colin was the Sr. VP, Cardiovasc. Prod. of Aravive, Inc.. (stock ticker symbol ARAV).
Also see all insider trading activities at Aravive, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | VSAR | 0 | $0 | 35,667 | $743,700 | 35,000 | $285,950 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | ANTH | 0 | $0 | 17,500 | $93,237 | 12,500 | $20,125 |
2012 | ANTH | 0 | $0 | 30,000 | $245,999 | 40,000 | $10,400 |
2011 | ANTH | 0 | $0 | 15,000 | $101,160 | 40,000 | $10,400 |
2010 | ANTH | 500 | $2,400 | 0 | $0 | 14,683 | $3,817 |
2. Anthera Pharmaceuticals Inc (ANTH)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-10-19 | VSAR | Sale | 667 | 2.55 | 1,700 |
2017-04-04 | VSAR | Option Ex | 35,000 | 8.17 | 285,950 |
2017-04-04 | VSAR | Sale | 35,000 | 21.20 | 742,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-11-13 | ANTH | Sale | 12,500 | 5.31 | 66,337 |
2015-11-13 | ANTH | Option Ex | 12,500 | 1.61 | 20,125 |
2015-11-11 | ANTH | Sale | 5,000 | 5.38 | 26,900 |
2012-02-23 | ANTH | Option Ex | 40,000 | .26 | 10,400 |
2012-02-03 | ANTH | Sale | 30,000 | 8.20 | 245,999 |
2011-11-08 | ANTH | Option Ex | 15,000 | .26 | 3,900 |
2011-11-08 | ANTH | Sale | 15,000 | 6.74 | 101,160 |
2011-07-12 | ANTH | Option Ex | 15,000 | .26 | 3,900 |
2011-06-29 | ANTH | Option Ex | 10,000 | .26 | 2,600 |
2010-09-21 | ANTH | Option Ex | 14,683 | .26 | 3,817 |
2010-08-18 | ANTH | Buy | 500 | 4.80 | 2,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hislop Colin (Sr. VP, Cardiovasc. Prod. of Aravive, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.